Stock Events

Stock Events

Quest Diagnostics 

$190.84
241
-$0.66-0.34% Tuesday 20:00

Statistics

Day High
191.7
Day Low
189.18
52W High
211.91
52W Low
166.42
Volume
423,152
Avg. Volume
-
Mkt Cap
20.97B
P/E Ratio
21.27
Dividend Yield
1.8%
Dividend
3.44

Upcoming

7
JUL
Dividend Ex
Estimated
 
21
JUL
Dividend Payment
Estimated
 
5
OCT
Dividend Ex
Estimated
 
20
OCT
Dividend Payment
Estimated
 
13
JAN 27
Dividend Ex
Estimated
 

Dividends

1.8%Dividend Yield
Apr 26
$0.86
Jan 26
$0.8
Oct 25
$0.8
Jul 25
$0.8
Apr 25
$0.8
10Y Growth
7.9%
5Y Growth
6.91%
3Y Growth
6.6%
1Y Growth
7.3%

Earnings

28JulExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
2.15
2.38
2.6
2.83
Expected EPS
2.826738
Actual EPS
N/A

Financials

8.99%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
22.07BRevenue
1.98BNet Income

Analyst Ratings

223Average Price Target
The highest estimate is 235.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
38%
Hold
63%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DGX. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Labcorp
LH
Mkt Cap21.06B
Laboratory Corporation of America Holdings operates as a direct competitor, offering similar clinical laboratory and end-to-end drug development services.
Bio-Rad Laboratories
BIO
Mkt Cap6.93B
Bio-Rad Laboratories, Inc. provides a range of products and systems used to separate complex chemical and biological materials, directly competing in the diagnostics and research market.
Thermo Fisher Scientific
TMO
Mkt Cap174.37B
Thermo Fisher Scientific Inc. offers similar diagnostic test products and services, competing in the life sciences and healthcare sectors.
Danaher
DHR
Mkt Cap123.97B
Danaher Corporation operates in the diagnostics and research sector, offering products and services that compete with Quest Diagnostics in the healthcare diagnostics field.
Agilent Technologies
A
Mkt Cap32.36B
Agilent Technologies, Inc. provides instruments, services, consumables, applications, and expertise, competing in the life sciences and diagnostics sectors.
Guardant Health
GH
Mkt Cap11.61B
Guardant Health, Inc. specializes in liquid biopsy tests, which are part of the growing diagnostics market, competing with Quest Diagnostics in cancer diagnostics.
Neogenomics
NEO
Mkt Cap1.17B
NeoGenomics, Inc. specializes in cancer diagnostics and pharma services, directly competing with Quest Diagnostics in the oncology diagnostics market.
Myriad Genetics
MYGN
Mkt Cap466.55M
Myriad Genetics, Inc. focuses on molecular diagnostic tests, competing in the personalized medicine and genetic testing market.

About

There is no Profile data available for QDI.SG.
Show more...
CEO
Mr. James E. Davis
Employees
55000
Country
United States
ISIN
US74834L1008

Listings

F
DE
QDI.F
MI
IT
1QDX.MI
STU
DE
QDI.STU
LSE
GB
0KSX.LSE

0 Comments

Share your thoughts

FAQ

What is Quest Diagnostics stock price today?▼
The current price of DGX is $190.84 USD — it has decreased by -0.34% in the past 24 hours. Watch Quest Diagnostics stock price performance more closely on the chart.
What is Quest Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quest Diagnostics stocks are traded under the ticker DGX.
Is Quest Diagnostics stock price growing?▼
DGX stock has risen by +0.8% compared to the previous week, the month change is a -4.08% fall, over the last year Quest Diagnostics has showed a +8.36% increase.
What is Quest Diagnostics market cap?▼
Today Quest Diagnostics has the market capitalization of 20.97B
When is the next Quest Diagnostics earnings date?▼
Quest Diagnostics is going to release the next earnings report on July 28, 2026.
What were Quest Diagnostics earnings last quarter?▼
DGX earnings for the last quarter are 2.5 USD per share, whereas the estimation was 2.37 USD resulting in a +5.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quest Diagnostics revenue for the last year?▼
Quest Diagnostics revenue for the last year amounts to 22.07B USD.
What is Quest Diagnostics net income for the last year?▼
DGX net income for the last year is 1.98B USD.
Does Quest Diagnostics pay dividends?▼
Yes, DGX dividends are paid quarterly. The last dividend per share was 0.86 USD. As of today, Dividend Yield (FWD)% is 1.8%.
How many employees does Quest Diagnostics have?▼
As of May 06, 2026, the company has 55,000 employees.
In which sector is Quest Diagnostics located?▼
Quest Diagnostics operates in the Health & Wellness sector.
When did Quest Diagnostics complete a stock split?▼
The last stock split for Quest Diagnostics was on June 21, 2005 with a ratio of 2:1.
Where is Quest Diagnostics headquartered?▼
Quest Diagnostics is headquartered in Secaucus, United States.